Anti-infective Agents Market to Grow with a CAGR of 1.18% through 2028
Increase in the incidence of infectious disease and increase in the
aging population is expected to drive the Global Anti-infective Agents Market
growth in the forecast period, 2024-2028.
According to TechSci Research report, “Anti-infective
Agents Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2028”, the Global Anti-infective Agents Market stood
at USD 136.89 million in 2022 and is anticipated to grow with a CAGR of 1.18%
in the forecast period, 2024-2028. The awareness among individuals regarding Anti-infective
Agents has led to favorable market conditions for the global Anti-infective
Agents market. Several factors contribute to the growth of various Anti-infective
Agents products.
The persistent and evolving threat of infectious
diseases remains a primary driver for the growth of the Anti-infective Agents
market. New pathogens, antimicrobial resistance, and the emergence of novel
infections continuously challenge public health. The need for effective
treatments to combat these infectious diseases propels the demand for
anti-infective agents.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Anti-infective Agents Market.”
Significant progress in drug development techniques,
molecular biology, and genomics has led to the discovery and creation of more
effective and targeted anti-infective agents. These advancements enable
pharmaceutical companies to develop innovative drugs with improved efficacy and
reduced side effects. The continuous research and development in this field
contributes to the market's growth.
In August 2023, Gilead announced that the U.S. Food
and Drug Administration (FDA) has approved Veklury® (remdesivir) to treat
COVID-19 in people with mild to severe hepatic impairment with no dose
adjustment. Veklury® is the first and only antiviral medication approved for
the treatment of COVID-19 in patients with hepatic impairment.
Recent global pandemics, such as COVID-19, have
emphasized the importance of preparedness in the face of infectious disease
outbreaks. Governments, healthcare organizations, and pharmaceutical companies
are increasingly investing in research, stockpiling, and the development of
antiviral and antibacterial agents to address potential pandemics, thereby
boosting the Anti-infective Agents market.
In today's fast-paced world, infectious diseases can
spread quickly. Anti-infective agents are essential for controlling outbreaks
and preventing the rapid transmission of infections, especially in densely
populated urban areas and during mass gatherings. The global interconnectedness
of our world makes it susceptible to pandemics. Fast and effective response to
pandemic threats is vital. Anti-infective agents are instrumental in treating
and preventing infectious diseases during pandemics, helping to limit their
impact on public health and the economy. In busy healthcare settings, the risk
of healthcare-associated infections is high. Anti-infective agents are
essential for managing and preventing infections within hospitals and clinics,
ensuring that patients can receive medical care safely and without added
complications. Travel and tourism are major industries that contribute to
global economic growth. Anti-infective agents are essential for travelers,
protecting them from infections they may encounter in new regions. This enables
people to explore the world with confidence.
The growing awareness among consumers regarding health
and wellness has shifted the focus towards the ideology of "prevention is
better than cure." As a result, more individuals are relying on
nutraceuticals, functional foods, and dietary and Anti-infective Agents to lead
a healthy and disease-free life.
In recent times, the world has faced the COVID-19
pandemic, which has highlighted the crucial role of anti-infective agents.
These agents are essential for the treatment of COVID-19 patients, helping to
manage symptoms, reduce severe cases, and save lives. Moreover, they are
integral to vaccine development and testing, which is vital in controlling the
spread of the virus. The global challenge of antimicrobial resistance is of
increasing concern. Many pathogens are developing resistance to existing
treatments, making new anti-infective agents indispensable. These agents are
essential for addressing drug-resistant infections and ensuring that patients
can receive effective treatments. Healthcare settings have been under scrutiny
due to the risk of hospital-acquired infections. Anti-infective agents are
crucial in managing and preventing these infections, which are especially
concerning during recent times when healthcare systems are under strain.
However, the Antimicrobial Resistance (AMR) may hinder market growth. Moreover,
challenges related to Drug Development and Regulatory and Market Access Hurdles
may pose obstacles to the Anti-infective Agents market in the near future.
The Global Anti-infective Agents Market is segmented
into type, route of administration, distribution channel, regional
distribution, and company.
Based on its type, the The Antiviral segment has
showcased substantial market size and consistent growth potential. This is
primarily due to the high prevalence of viral infections, including HIV,
hepatitis, and influenza, which necessitate effective antiviral agents for
treatment and prevention. The world's recent experiences with pandemics, such
as the COVID-19 outbreak, have highlighted the critical importance of antiviral
agents. Governments and healthcare organizations worldwide have increased their
focus on building stockpiles of antiviral medications to be prepared for
potential viral threats, which bolsters the demand for antiviral drugs.
Antiviral drug research and development have benefited from significant
technological advancements. This has led to the discovery of more effective and
targeted antiviral treatments with reduced side effects, which further fuels
the growth of this segment.
Based on region, North America segment is expected to
grow during the forecast period. The regional market is experiencing
notable growth, driven by several pivotal factors. These include the presence
of advanced healthcare infrastructure, a growing level of awareness among
healthcare professionals and clinicians, and a strong commitment from the
government to enhance public health awareness and education. This commitment is
evident through various initiatives aimed at promoting infection prevention,
vaccination programs, and the responsible use of antibiotics. Furthermore, the
market benefits from favorable reimbursement policies and the substantial
purchasing power of the population, particularly for high-cost pharmaceuticals,
which collectively contribute to the positive trajectory of market expansion.
The Asia-Pacific market is poised to be the
fastest-growing market, offering lucrative growth opportunities for
Anti-infective Agents players during the forecast period. Factors such as The
regional market's significant expansion can be credited to several key factors,
including the robust presence of generic pharmaceutical companies, a notable
upswing in economic stability, and a steady increase in disposable income
levels among the populace. Furthermore, the burgeoning aging demographic and
their heightened vulnerability to infections are anticipated to serve as
significant drivers for the continued growth of the regional market in the
forthcoming years.
Major companies operating in Global Anti-infective
Agents Market are:
- Pfizer Inc.
- Abbott Inc.
- Gilead Sciences, Inc.
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- B. Braun SE
- Xellia Pharmaceuticals Inc
- Mankind Pharma Ltd.
- Bayer AG
- AstraZeneca Plc
Download Free Sample Report
Customers can also request for 10% free customization
on this report.
“The Drug Development Advancements and Aging
Population and Chronic Diseases spending are key drivers of the Anti-infective
Agents market. In recent years, the growing Ongoing advancements in drug
development, including targeted therapies, combination therapies, and precision
medicine, contribute to the growth of the market. Moreover, the growing
consumer emphasis on preventative healthcare has enhanced production and
marketing efforts. To meet the demands of the market, manufacturers are
increasingly incorporating cutting-edge technologies with high production
efficiency. Rising consumer acceptance and continuous product innovation will
further ensure the growth of the Anti-infective Agents market in the coming
years.,” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Anti-infective Agents Market – Global
Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 Segmented
By Type (Antibacterials, Antivirals, Antifungals), By Route of Administration
(Topical, Oral, IV, Others), By Distribution Channel (Hospital Pharmacies,
Retail Pharmacies, Specialty Pharmacies, E-Commerce, Others), By Region,
Competition”, has evaluated the future growth potential of Global Anti-infective
Agents Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Anti-infective
Agents Market.
Contact Us-
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
M:
+13322586602
Email: [email protected]
Website: www.techsciresearch.com